Filter
1960
Filtered Results: 1960
Text search:
drug
regimens
Featured
Recommendations
204
New Publications
542
Language
Document type
No document type
1312
Guidelines
257
Studies & Reports
225
Manuals
55
Fact sheets
34
Strategic & Response Plan
32
Training Material
23
Situation Updates
7
Infographics
7
Resource Platforms
4
Brochures
2
Online Courses
2
Countries / Regions
India
119
South Africa
59
Kenya
53
Ethiopia
50
Tanzania
46
Western and Central Europe
42
Global
39
Uganda
37
Nigeria
35
Zambia
34
Nepal
31
Eastern Europe
31
Rwanda
29
Africa
28
Ghana
22
Ukraine
21
Latin America and the Carribbean
21
Liberia
21
Bangladesh
19
Malawi
18
Philippines
18
Namibia
18
Myanmar / Burma
18
Asia
17
Zimbabwe
16
Cambodia
15
Sierra Leone
12
Mozambique
12
Russia
12
Lesotho
11
South–East Asia Region
11
Indonesia
11
Botswana
10
Eswatini/ Swaziland
8
Colombia
7
Thailand
7
Cameroon
7
Senegal
7
Congo, Democratic Republic of
6
Brazil
6
Albania
5
Haiti
5
West and Central Africa
5
East and Southern Africa
5
Georgia
5
Tajikistan
4
Syria
4
USA
4
Venezuela
4
Argentina
4
Pakistan
4
Benin
3
China
3
Estonia
3
Germany
3
Western Pacific Region
3
Vietnam
3
Bhutan
3
South Sudan
3
Timor Leste/ East Timor
2
Burkina Faso
2
Afghanistan
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Paraguay
2
North America
2
Jamaica
2
Sri Lanka
2
Sudan
2
Romania
2
Iraq
2
Somalia
2
North Macedonia
1
North Korea
1
El Salvador
1
Gambia
1
Chile
1
Iran
1
Fiji
1
Laos
1
Peru
1
Morocco
1
Guinea
1
Jordan
1
Saudi Arabia
1
Denmark
1
Tunisia
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Lebanon
1
Papua New Guinea
1
Greece
1
Central African Republic
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
262
Guidelines
172
Studies & Reports
107
Drugs & Medical Equipment
84
Policies
69
TB
69
Capacity Building
60
Women & Child Health
58
HIV & STI
53
Statistics
48
Pediatrics
40
Disease Prevention & Control
28
Paediatrics
27
Malaria
22
Hepatitis
19
Community Health
15
Gynaecology & Obstetrics
15
Maternal Health
15
Non-communicable Diseases
12
COVID-19
11
Reproductive Health
11
Cardiovascular Diseases
10
Diabetes
8
Under-5 nutrition
7
Humanitarian Aid
7
Vaccine-preventable Diseases
7
Clinical Guidelines
7
Demograhic Health Surveys DHS
7
Primary Health Care
7
Communicable Diseases
6
Community Health
6
Countries
6
General Guidelines
6
Leprosy
6
NTDs & Others
6
Leishmaniasis
6
Neonatal Care
6
Pharmacy & Technologies
6
Clinical Training
5
Family Planning
5
Child Health
5
Dermatology
5
Vector Control
5
Palliative Care
5
Cancer Treatment & Resources
5
Maternal & Child Health
5
Infection Control & Prevention (IPC)
5
NCD
5
Health Systems
5
Buruli Ulcer
4
Bacteriology
4
Sexual Violence
4
Chagas
4
Hemorrhagic Fever
4
Humanitarian Crisis
4
Leprosy
4
Respiratory Infections
4
Surgery & Anaesthesia
4
Communicable Diseases
4
Women & Child Health
4
General Guidelines
3
Monitoring & Evaluation
3
Virology
3
Public Health
3
Pharmaceutical Assessments
3
Diarrhoeal Disease/Cholera
3
Palliative Care
3
Rabies
2
Public Health
2
Helminthiasis
2
Pharmacy & Technology
2
Trachoma
2
Taeniasis/ Cysticercosis
2
Schistosomiasis
2
Lymphaticfilariasis
2
Cancer
2
MPOX - Monkeypox
2
Snakebites
2
Training Manuals
2
Quality Control & Assurance
2
COPD/Asthma
2
Needs Assessment
2
Parasitology
2
Age & Elderly
2
Dental & Eye Care
1
Emergency Health Kits
1
Hand Hygiene
1
Hematology
1
Online Courses & Platforms
1
Onchocerciasis
1
x MEDBOX Issue Brief & Annual Reports x
1
Other Cancer diseases
1
Non-communicable Diseases NCD
1
Sex. & Repr. Rights
1
Yersinia pestis (Plague)
1
Health System Strengthening
1
Child protection
1
Medical Devices & Equipment
1
Information, Education and Communication (IEC)
1
Disabilities
1
Mental Health
1
Other
1
Immunization
1
Nutrition
1
Neurology & Psychology
1
Laboratory Quality Assurance
1
Physiotherapy & Rehabilitation
1
Global Health
1
Radiology and Diagnostic
1
Food Security & Nutrition
1
Toolboxes
Reports & Studies
59
Children & Adolescents
48
Drug resistant TB
48
Eastern Europe and central Asia
41
Treatment & Prevention
35
Prevention & Control
35
Adults
35
Children
29
Clinical Aspects, Treatment & Prevention
28
Detection & Diagnosis
28
Antiretroviral Treatment ART
27
TB & Prisoners
24
TB/HIV Coinfection
21
Training
20
ART Drug Resistance
18
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
18
Clinical Aspects
17
Essential Medicines & Devices Lists
17
Reports
16
Research & Access
16
Rational use of Medicine
15
Eastern Europe & Central Asia
15
General Reports
14
Policies
14
Treatment Guidelines HIV
14
Children/Adolescents Mental Disorders
14
Childhood TB
13
Country specific
13
General
13
Clinical Guidelines
13
TB & Other Vulnerable Populations
12
Advocacy & Communication
12
Disease Prevention & Control
12
HIV in Key Populations
12
SEAR (South-east Asia Region)
12
Policies & Strategies
11
Opportunistic Infections
11
HIV
11
Global
11
Universal Health Coverage UHC and 90-90-90 Strategy
11
Asia and Pacific
11
Policies and guidelines
11
Co-Morbidities (except TB)
11
Essential Medicines
10
HIV and coinfection
10
Reports & Studies Children HIV
10
HIV testing & services
9
Policies & Strategies
9
Drug resistance
9
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
9
Epilepsy
9
International
9
TB/HIV
9
Clinical Guidelines
9
TB
9
Ukraine
8
Treatment Guidelines
8
HIV &TB
8
Prevention & Strategies
8
General
8
TB/HIV Global
8
HIV service delivery
8
Adherence
7
Laboratory
7
General
7
Country specific documents
7
Pharmacy Practice
7
General Guidelines for Rational Use
7
Neurological Disorders
7
Prevention of mother-to-child transmission (PMTCT)
7
Lobby and Advocacy
7
Epidemiology
7
Kenya
7
Surveillance
6
Vaccines & Immunization
6
Rwanda
6
Research
6
Drug resistance
6
Studies
6
Health Personnel
6
Global Impact: Socio-economic, health services, TB & HIV
6
Supply Chain & Store Management
6
Epilepsy
6
Studies & Reports
6
Health Worker
6
Clinical Aspects & Diagnosis
6
Nutrition
6
Latin America & the Carribean
6
Eastern and Southern Africa
6
Treatment & Clinical Management
6
TB & Drug Abuse
5
South Africa
5
HIV testing & disclosure
5
Laboratory
5
Prevention & Control
5
People who injecting Drugs
5
Country Guidelines
5
Clinical Guidelines
5
Country Specific
5
Essential Medicines & Medical Devices
5
TB/COVID-19
5
Clinical Aspects & Diagnostics
5
Studies & Reports
5
Overview, Studies & Reports
5
Access to treatment and laboratory
5
Prevention & Strategies
5
Substance Use Disorders & Addiction
5
Bipolar Affective Disorders
5
Assessment
5
Agriculture & Veterinary
4
Moldova
4
Prevention Guidelines
4
Training Manuals
4
Hepatitis
4
Public Health
4
Others
4
TB
4
Tools for Rational use
4
Clinical aspects
4
Ethiopia
4
Community Health Workers CHW
4
Colombia
4
Prices and Patents
4
Studies & Reports
4
General Aspects
4
Prophylactic Treatment
4
Stewardship
4
Western & Central Europe
4
South-east Asia Region
4
Behaviour Change/Life Skill Education
3
Assessment & Studies
3
HIV in Children and mental health
3
Azerbaijan
3
Violence & Protection
3
Policies & Programmes
3
Eastern Mediterranean Region
3
Opoids
3
National Policies
3
Namibia
3
Eastern Europe
3
Latin America
3
Georgia
3
HIV and COVID-19
3
Latin America
3
Standard Operating Procedure (SOP)
3
Handbooks & Manuals
3
Midwives
3
Model Formulary
3
Pharmacy Management
3
Pharmacovigilance
3
Mental Disorders
3
General
3
Chagas
3
Clinical Aspects & Diagnostics
3
Prevention & Control
3
General Information & Methodology
3
Diagnosis
3
Romania
3
others
3
Ghana
3
Community Worker
3
Malawi
3
Uganda
3
Testing Guidelines
3
Tajikistan
3
Epidemiology
3
Depression
3
Africa
2
Treatment Guidelines
2
Children with Disabilities
2
IPC
2
HIV surveillance
2
WPRO (Western Pacific Region)
2
Schizophrenia
2
Latin America
2
Clinical Guidelines
2
Transgender People
2
General Mental Health Guidelines
2
IEC Materials
2
General Studies & Reports
2
Prophylaxis
2
SOPs
2
Mozambique
2
Health & Refugee
2
Discrimination & Stigma
2
Training Supporting Material mhGAP
2
Workplace
2
HIV / AIDS
2
Russia
2
Supporting tools
2
Essential List
2
Infection Control General
2
Diagnostics & Laboratory Guidance
2
Scientific & Research Studies
2
Gender Aspects
2
Paediatrics
2
Health Care Professionals & Spirituality
2
Oxygen Therapy
2
Mythbusters/Misinformation
2
Biontech/Pfizer Comirnaty
2
Vaxzevria (Astra Zeneca)
2
Nurses
2
Estonia
2
Pocket Cards
2
Pharmaceutical Assessments
2
Quality Assurance
2
Pediatrics
2
Women & Maternal Health
2
Argentina
2
Pharmaceutical Dosage Forms
2
Guidelines & Manuals
2
Health Care In Conflict Settings
2
MPOX - Monkeypox
2
Leishmaniasis
2
Strategies & Roadmaps
2
Clinical Aspects & Diagnostics
2
Statistics & Facts
2
Studies & Reports
2
Studies & Reports
2
Health Financing Toolbox
2
Prevention & Strategies
2
Women
2
Clinical Aspects & Diagnosis
2
Global Overview
2
War Surgery & Wound Care
2
Protection
2
Assessment & Response
2
Human Rights & the Right to Health
2
Asia
2
AR (African Region)
2
Education of students & professionals
2
Germany
2
General Public
2
HIV / AIDS
2
Nigeria
2
Others
2
Kazakhstan
2
AmR (Region of Americas)
2
Learning Disabilities
2
Guidelines CBR
2
Prisoners
2
Neurological disorders, Others
2
Training & Capacity Building
2
Preparedness & Prevention
2
Drugs
1
Outbreak Prevention & Control
1
Alcohol
1
Psychosocial Support (MHPSS)
1
Biosafety
1
Clinical Guidelines
1
Meningitis Prevention & Control
1
Intellectual Disability
1
Global Mental Health
1
Clinical Guidelines
1
Ebola Prevention & Control
1
Chemical Attacks
1
Europe
1
Hand Hygiene
1
Key Resources
1
Influenza Prevention & Control
1
Surgery & Rehabilitation
1
Clinical Guidelines
1
Pediatrics
1
Zambia
1
Plague
1
Training Manuals
1
Substance Use Disorders, Others
1
Influenza
1
Context, Facts & Travel Advice
1
Children
1
Social Mobilisation
1
Infection Control
1
Social Worker
1
Orphans & vulnerable children
1
Sexually Transmitted Infections
1
Communication & Training
1
El Niño
1
Hepatitis
1
IEC Materials
1
Vaccination
1
African Region
1
Standard Precautions
1
Human Rights
1
Laboratory
1
Child Health / Pediatrics
1
Mental Health Studies & Reports
1
Belarus
1
Laboratory & Sampling
1
Sustainable Development Goals
1
Sex Worker
1
Communication & Training
1
Prevention & Preparedness
1
Research & Development
1
Livestock production
1
Infection Prevention & Hygiene
1
Context & Facts, Travel Advice
1
Clinical Aspects
1
For Pregnant Women
1
Training, others
1
Child Protection
1
COVID-19
1
Pastoral Care
1
Palliative Care
1
Medical & Community Masks
1
Hospital Readiness/Essential Health Services
1
Blood Supply
1
Situation Reports COVID-19
1
RCCE Guides & Manuals
1
At Home
1
Access & Strategy
1
Vaccine Candidates & Research
1
Psychosocial Support
1
Logistics & Supply
1
Fair Allocation & Ethical Aspects
1
SARS-CoV-2 Variants
1
Long COVID/ Post-COVID Syndrome
1
Sputnik V
1
Research & Pipeline
1
Others
1
Others
1
Studies & Reports
1
Palliative Care
1
Brazil
1
Other Countries
1
Wound management
1
Falsified & Substandard
1
Traditional & Herbal Medicines
1
Surgery
1
General documents One Health
1
Situation Reports & Updates
1
Information Refugees Ukraine
1
Prevention & Measures
1
Antimicrobial Resistance (AMR)
1
Zoonoses
1
Non-communicable Diseases NCD
1
Nuclear & Chemical Hazards
1
MPOX - Monkeypox
1
Appeals & Response Plans
1
Capacity Building & Resources
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Information & Education Material (IEC)
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Studies & Reports
1
Patient Safety
1
NTDs General
1
Vector control
1
Echinocccosis
1
Mycetoma, Chromoblastomycosis & other deep mycosis
1
Snakebite envenoming
1
West and central Africa
1
Statistics & Facts
1
Clinical Aspects & Diagnosis
1
Studies & Reports
1
Studies & Reports
1
Clinical Guidelines
1
Botswana
1
General
1
Liberia
1
Hearing Loss & Deafness
1
Alzheimer's Disease & Dementia
1
Assessment & Response
1
Regional Reports & Guidelines, others
1
Mental disorders, others
1
Policy
1
Regions
1
Tuberculosis
1
Technical Information
1
Lesotho
1
Situation Reports & Updates
1
Vision Loss & Blindness
1
International
1
Chikungunya Prevention & Control
1
Zika Prevention & Control
1
Tobacco
1
Anxiety Disorders
1
Epidemiology
1
Community-based Mental Health Care
1
MHPSS Guidelines
1
Community Based Rehabilitation (CBR)
1
Paediatrics
1
Infection Control
1
Chikungunya
1
Key Resources
1
AMR
1
Meningitis & Encephalitis
1
Volunteers
1
Global Health Ethics
1
Plague Prevention & Control
1
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
This study aimed to understand the patterns of HIV drug resistance in pregnant women in Mozambique. This might help in tailoring optimal regimens for prevention of mother to child transmission of HIV (pMTCT) and antenatal care.
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD...
The term "Programmatic Management of Drug Resistant TB" (PMD...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
This e-course will guide you through the essentials of latest existing WHO guidelines and policy recommendations on drug-resistant TB. You will also learn more about the rationale behind the WHO recommendations for the management of DR-TB, implementation considerations for different regimens for eli...
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical trials have recently shown...
The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public health problem throughout Latin America. Current therapeutic options are characterised by limited efficacy, long treatment regimens and frequent toxic side-effects. Advances in this area have been compromised by gaps...
Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin, diethylcarbamazine and albendazole) or DA (diethylcarbamazine and ...
